Ascendis Pharma A (ASND) Accounts Payables (2012 - 2026)
Ascendis Pharma A (ASND) posted Accounts Payables of $120.79 million for the quarter ended Jun 30, 2026, up 13.9% from $106.08 million a year earlier and up 31.3% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Accounts Payables (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A's Accounts Payables came in at $102.43 million, down 1.8% from the prior year.
- Annual Accounts Payables shows a five-year compound annual growth rate of 31.4% (years ended Dec 2020 to Dec 2025).
- In prior years, Ascendis Pharma A's Accounts Payables was $104.33 million in the year ended Dec 31, 2024 (+2.0%), $102.29 million in the year ended Dec 31, 2023 (-3.9%), $106.48 million in the year ended Dec 31, 2022 (+56.7%) and $67.97 million in the year ended Dec 31, 2021 (+160.4%).
- The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Accounts Payables since the quarter ended Sep 30, 2023.
- On a year-over-year basis, Accounts Payables has increased in each of the last four quarters, with an average decline of 2.5% over the last eight quarters.
- The strongest year-over-year quarter for Accounts Payables in the past five years was the quarter ended Dec 31, 2021, with growth of 160.4%; the weakest was the quarter ended Sep 30, 2024, with a decline of 37.5%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $92.01 million (quarter ended Mar 31, 2026), $105.53 million (quarter ended Dec 31, 2025) and $91.89 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Ascendis Pharma A | 14.14 Bn | 10.38 Bn | 362.22 Mn | 120.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 120.79 Mn |
| Mar 31, 2026 | 92.01 Mn |
| Dec 31, 2025 | 105.53 Mn |
| Sep 30, 2025 | 91.89 Mn |
| Jun 30, 2025 | 106.08 Mn |
| Mar 31, 2025 | 88.75 Mn |
| Dec 31, 2024 | 103.01 Mn |
| Sep 30, 2024 | 82.66 Mn |
| Jun 30, 2024 | 107.18 Mn |
| Mar 31, 2024 | 102.69 Mn |
| Dec 31, 2023 | 101.75 Mn |
| Sep 30, 2023 | 132.32 Mn |
| Jun 30, 2023 | 132.98 Mn |
| Mar 31, 2023 | 141.08 Mn |
| Dec 31, 2022 | 103.08 Mn |
| Sep 30, 2022 | 86.81 Mn |
| Jun 30, 2022 | 80.01 Mn |
| Mar 31, 2022 | 79.33 Mn |
| Dec 31, 2021 | 67.97 Mn |
| Sep 30, 2021 | 90.18 Mn |
API Access
Ascendis Pharma A Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();